THE DEVELOPMENT OF A MULTIMODAL ANTIBODY PLATFORM TO EXTEND THE WINDOW OF IMMUNOTHERAPEUTIC INTERVENTION. THE OVERALL OBJECTIVE OF THE WORK OUTLINED IN THIS CONTRACT IS TO CRITICALLY EVALUATE THE UTILITY OF THE VHH AS A PLATFORM MCM TECHNOLOGY FOR VI

DEFINITIVE CONTRACT won by EITR BIOLOGICS, INC. · work in SAN DIEGO, CA
$33,059,642
RecipientEITR BIOLOGICS, INC. UEI HX49LZLY32G5
Award ID75A50123C00060
Award amount$33,059,642
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC3650
Set-asideUnrestricted
Start dateSep 22, 2023
End dateSep 30, 2027
Place of performanceSAN DIEGO, CA
Record updatedJul 28, 2026

View the official award record

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids